Shares of Pluri Inc. (NASDAQ:PLUR – Get Free Report) dropped 4.5% on Tuesday . The stock traded as low as $5.06 and last traded at $5.09. Approximately 40,459 shares changed hands during trading, an increase of 121% from the average daily volume of 18,346 shares. The stock had previously closed at $5.33.
Pluri Trading Down 4.5 %
The company has a debt-to-equity ratio of 4.44, a current ratio of 5.90 and a quick ratio of 5.90. The company has a market cap of $28.30 million, a PE ratio of -0.84 and a beta of 1.64. The company’s 50 day simple moving average is $5.08 and its two-hundred day simple moving average is $5.39.
Pluri (NASDAQ:PLUR – Get Free Report) last announced its earnings results on Wednesday, September 18th. The company reported ($2.98) earnings per share for the quarter. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%. The company had revenue of $0.26 million for the quarter.
About Pluri
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Featured Articles
- Five stocks we like better than Pluri
- What is a SEC Filing?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- The Basics of Support and Resistance
- Netflix Is On Track To Hit $1,000 By Christmas
- What is the NASDAQ Stock Exchange?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.